The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2

Lieve Verlinden1, Isabelle Vanden Bempt, Guy Eelen

  • 1Laboratorium voor Experimentele Geneeskunde en Endocrinologie and CMPG/ESAT, Katholieke Universiteit Leuven, Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium.

Cancer Research
|July 20, 2007
PubMed

Insights

Checkpoint kinase 1 (Chk1) and Claspin expression is linked to aggressive breast cancer. Their levels were highest in high-grade, triple-negative tumors, suggesting potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Cycle Regulation

Background:

  • Checkpoint kinase 1 (Chk1) and Claspin are DNA-damage checkpoint proteins previously shown to be downregulated by 1,25-dihydroxyvitamin D(3).
  • 1,25-dihydroxyvitamin D(3) is a known inhibitor of cell proliferation.

Purpose of the Study:

  • To investigate the transcriptional regulation of Chk1 and Claspin.
  • To determine the expression levels of Chk1 and Claspin in human breast cancer tissue.
  • To correlate Chk1, Claspin, and E2F1 expression with clinicopathologic variables in breast cancer.

Main Methods:

  • Transient transfection experiments in MCF-7 breast cancer cells to assess promoter activity.
  • Quantitative reverse transcriptase-PCR analysis of Chk1, Claspin, and E2F1 transcript levels in 103 primary invasive breast carcinomas.
  • Comparison of transcript levels with clinicopathologic variables including histologic grade, estrogen receptor (ER), progesterone receptor (PR), and HER2 status.

Main Results:

  • Promoter activities of Chk1 and Claspin were regulated by E2F family transcription factors.
  • Strong correlation observed between Chk1 and Claspin transcript levels.
  • Transcript levels of Chk1, Claspin, and E2F1 were highest in histologic grade 3 tumors and in ER/PR-negative tumors.
  • Chk1 expression was significantly elevated in grade 3 triple-negative (ER-/PR-/HER-2-) breast carcinomas.

Conclusions:

  • E2F transcription factors regulate Chk1 and Claspin.
  • Chk1 and Claspin expression levels correlate with aggressive breast cancer subtypes, including triple-negative breast cancer.
  • Further research into Chk1 inhibitors for triple-negative breast carcinomas is warranted due to limited treatment options.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...